Fierce Biotech November 29, 2023
Conor Hale

Orthofix has found itself a new leader after the board ousted its previous chief and other members of its C-suite earlier this year over what they described as “offensive conduct.”

Massimo Calafiore is slated to take the helm of the spine implant and orthopedics player as president and CEO in early 2024. At the moment, Calafiore serves as CEO of the Italian orthopedics developer Lima—a company that has inked an 800 million euro deal to be acquired by Enovis, the nascent medtech that spun out from the Colfax brand last year.

In September, Orthofix disclosed that it had issued for-cause terminations to its president and CEO, Keith Valentine, as well as Chief Financial Officer John Bostjancic and Chief Legal Officer...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article